Sbir topic 307 phase i novel imaging agents to expand the clinical toolkit for cancer diagnosis, staging, and treatment
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201100122C
- Awardee
-
Lumicell Inc. UEI LKQGSHLAXVW5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $248,461
Award facts
- Opportunity
-
- N43CO1703494 Solicitation number
- Contract value 100% obligated
- $248,461.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 16 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Waltham, MA 02451, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $248,461 |
About this award
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Lumicell Inc. The contract, valued at $248,461.00, is for the development of novel imaging agents to expand the clinical toolkit for cancer diagnosis, staging, and treatment. The contract has a firm fixed-price pricing type and a period of performance through December 5, 2013. Lumicell Inc. is a for-profit organization and manufacturer of goods that specializes in developing innovative medical imaging technologies, particularly focused on cancer detection and treatment. This contract award is part of the NCI's efforts to support small business research and development in the area of cancer imaging technologies.
Quick answers
Who was awarded contract HHSN261201100122C?
HHSN261201100122C was awarded to Lumicell Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2011.
How much is contract HHSN261201100122C worth?
The government has obligated $248,461 on HHSN261201100122C.
Was contract HHSN261201100122C competed?
The extent of competition for HHSN261201100122C was full and open competition after exclusion of sources. The government received 16 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award